Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Gross Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Gross Margin for 2 consecutive years, with 50.63% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 1100.0% to 50.63% in Q4 2025 year-over-year; TTM through Oct 2025 was 46.4%, a 1199.0% increase, with the full-year FY2025 number at 40.47%, up 3917.0% from a year prior.
  • Gross Margin was 50.63% for Q4 2025 at Kestra Medical Technologies, up from 45.69% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 50.63% in Q4 2025 to a low of 10.63% in Q1 2024.